Literature DB >> 11260798

Prions and the lymphoreticular system.

C Weissmann1, A J Raeber, F Montrasio, I Hegyi, R Frigg, M A Klein, A Aguzzi.   

Abstract

Following intracerebral or peripheral inoculation of mice with scrapie prions, infectivity accumulates first in the spleen and only later in the brain. In the spleen of scrapie-infected mice, prions were found in association with T and B lymphocytes and to a somewhat lesser degree with the stroma, which contains the follicular dendritic cells (FDCs) but not with non-B, non-T cells; strikingly, no infectivity was found in lymphocytes from blood of the same mice. Transgenic PrP knockout mice expressing PrP restricted to either B or T lymphocytes show no prion replication in the lymphoreticular system. Therefore, splenic lymphocytes either acquire prions from another source or replicate them in dependency on other PrP-expressing cells. The essential role of FDCs in prion replication in spleen was shown by treating mice with soluble lymphotoxin-beta receptor, which led to disappearance of mature FDCs from the spleen and concomitantly abolished splenic prion accumulation and retarded neuroinvasion following intraperitoneal scrapie inoculation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11260798      PMCID: PMC1088423          DOI: 10.1098/rstb.2000.0763

Source DB:  PubMed          Journal:  Philos Trans R Soc Lond B Biol Sci        ISSN: 0962-8436            Impact factor:   6.237


  12 in total

1.  The mechanism of internalization of glycosylphosphatidylinositol-anchored prion protein.

Authors:  Claire Sunyach; Angela Jen; Juelin Deng; Kathleen T Fitzgerald; Yveline Frobert; Jacques Grassi; Mary W McCaffrey; Roger Morris
Journal:  EMBO J       Date:  2003-07-15       Impact factor: 11.598

Review 2.  Prion diseases and the gastrointestinal tract.

Authors:  G A Davies; Adam R Bryant; John D Reynolds; Frank R Jirik; Keith A Sharkey
Journal:  Can J Gastroenterol       Date:  2006-01       Impact factor: 3.522

Review 3.  Trehalose as a promising therapeutic candidate for the treatment of Parkinson's disease.

Authors:  Masoomeh Khalifeh; George E Barreto; Amirhossein Sahebkar
Journal:  Br J Pharmacol       Date:  2019-03-27       Impact factor: 8.739

4.  Human anti-prion antibodies block prion peptide fibril formation and neurotoxicity.

Authors:  Xing Wei; Yvonne Roettger; Bailin Tan; Yongzheng He; Richard Dodel; Harald Hampel; Gang Wei; Jillian Haney; Huiying Gu; Brian H Johnstone; Junyi Liu; Martin R Farlow; Yansheng Du
Journal:  J Biol Chem       Date:  2012-02-23       Impact factor: 5.157

5.  Intracellular re-routing of prion protein prevents propagation of PrP(Sc) and delays onset of prion disease.

Authors:  S Gilch; K F Winklhofer; M H Groschup; M Nunziante; R Lucassen; C Spielhaupter; W Muranyi; D Riesner; J Tatzelt; H M Schätzl
Journal:  EMBO J       Date:  2001-08-01       Impact factor: 11.598

6.  Lymphotoxin-alpha- and lymphotoxin-beta-deficient mice differ in susceptibility to scrapie: evidence against dendritic cell involvement in neuroinvasion.

Authors:  Michael B A Oldstone; Richard Race; Diane Thomas; Hanna Lewicki; Dirk Homann; Sara Smelt; Andreas Holz; Pandelakis Koni; David Lo; Bruce Chesebro; Richard Flavell
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

7.  Perturbation of T-cell development by insertional mutation of a PrP transgene.

Authors:  Mark Zabel; Christina Greenwood; Alana M Thackray; Bruce Pulford; Willem Rens; Raymond Bujdoso
Journal:  Immunology       Date:  2008-10-21       Impact factor: 7.397

8.  Immunization delays the onset of prion disease in mice.

Authors:  Einar M Sigurdsson; David R Brown; Maki Daniels; Richard J Kascsak; Regina Kascsak; Richard Carp; Harry C Meeker; Blas Frangione; Thomas Wisniewski
Journal:  Am J Pathol       Date:  2002-07       Impact factor: 4.307

9.  Chemically induced accumulation of GAGs delays PrP(Sc) clearance but prolongs prion disease incubation time.

Authors:  Tehila Mayer-Sonnenfeld; Dana Avrahami; Yael Friedman-Levi; Ruth Gabizon
Journal:  Cell Mol Neurobiol       Date:  2008-03-19       Impact factor: 5.046

10.  Anti-PrP Mab 6D11 suppresses PrP(Sc) replication in prion infected myeloid precursor line FDC-P1/22L and in the lymphoreticular system in vivo.

Authors:  Martin J Sadowski; Joanna Pankiewicz; Frances Prelli; Henrieta Scholtzova; Daryl S Spinner; Regina B Kascsak; Richard J Kascsak; Thomas Wisniewski
Journal:  Neurobiol Dis       Date:  2009-05       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.